It is noteworthy that the impact of FBXO11 expression on tumor grade is more likely to be seen in the early stages (I–II) of the tumor, when cancer cells are about to develop and have spread to a small extent (Table 1). The gene discussed is FBXO11; the disease is neoplasm.